Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Advances in Therapy
Published in: Advances in Therapy 10/2009

01-10-2009 | Original Research

Healthcare charges in patients who transition from ocular hypertension to primary open-angle glaucoma based on ophthalmic coding data

Authors: Louis R. Pasquale, John G. Walt, Lee S. Stern, Daniel Wiederkehr, Elisabetta Malangone, Margarita Dolgitser

Published in: Advances in Therapy | Issue 10/2009

Login to get access
Metadata
Title
Healthcare charges in patients who transition from ocular hypertension to primary open-angle glaucoma based on ophthalmic coding data
Authors
Louis R. Pasquale
John G. Walt
Lee S. Stern
Daniel Wiederkehr
Elisabetta Malangone
Margarita Dolgitser
Publication date
01-10-2009
Publisher
Springer Healthcare Communications
Published in
Advances in Therapy / Issue 10/2009
Print ISSN: 0741-238X
Electronic ISSN: 1865-8652
DOI
https://doi.org/10.1007/s12325-009-0073-y

Other articles of this Issue 10/2009

Advances in Therapy 10/2009 Go to the issue

Review

Insulin sensitizers in nonalcoholic fatty liver disease and steatohepatitis: Current status

Review

Anticholinergic treatment in airways diseases

Original Research

Adherence to infliximab maintenance therapy and health care utilization and costs by Crohn’s disease patients

Original Research

Mifepristone treatment of olanzapine-induced weight gain in healthy men

Original Research

The effects of combination glaucoma medications on ocular surface epithelial cells

Review

Skin tolerability associated with transdermal drug delivery systems: an overview
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits